ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SWTX SpringWorks Therapeutics Inc

43.38
0.00 (0.00%)
Pre Market
Last Updated: 04:05:56
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 34.30
Ask Price 68.97
News -
Day High

Low
18.00

52 Week Range

High
53.92

Day Low
Company Name Stock Ticker Symbol Market Type
SpringWorks Therapeutics Inc SWTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 43.38 04:05:56
Open Price Low Price High Price Close Price Prev Close
43.38
Trades Volume Avg Volume 52 Week Range
0 0 - 18.00 - 53.92
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 43.38 USD

SpringWorks Therapeutics (SWTX) Options Flow Summary

Overall Flow

Bearish

Net Premium

-613k

Calls / Puts

0.00%

Buys / Sells

50.00%

OTM / ITM

20.00%

Sweeps Ratio

0.00%

SpringWorks Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.2B 73.79M - 5.45M -325.1M -4.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

SpringWorks Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SWTX Message Board. Create One! See More Posts on SWTX Message Board See More Message Board Posts

Historical SWTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week43.9346.4338.9042.20892,079-0.55-1.25%
1 Month50.1352.2038.9044.31780,349-6.75-13.46%
3 Months44.5553.9238.9048.081,167,496-1.17-2.63%
6 Months22.4153.9218.0038.661,207,88220.9793.57%
1 Year23.7153.9218.0034.74897,89319.6782.96%
3 Years71.5389.745813.6036.18710,605-28.15-39.35%
5 Years24.5096.4813.6038.76544,59218.8877.06%

SpringWorks Therapeutics Description

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

Your Recent History

Delayed Upgrade Clock